Although their effects on heart failure outcomes remain neutral or modest, preclinical data suggest that GLP-1 RAs exert pleiotropic cardioprotective effects through the modulation of natriuretic peptide levels, suppression of cardiomyocyte apoptosis, inhibition of extracellular matrix remodeling, and enhancement of mitochondrial dynamics. Here, GCG is linked to heart failure.